MegaPro Biomedical Co

MegaPro Biomedical Co Employees

The The number of employees of MegaPro Biomedical Co (6827.TWO) as of Nov 12, 2026 is 20. In the previous year, The number of employees was 20.00 — a change of 0.00% (lower).

Employees

20

YoY

0.00%

Last updated:

In 2025, MegaPro Biomedical Co employed 20 people, a 0.00% change from the 20.00 number of employees in the previous year.

The MegaPro Biomedical Co Employees history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Employees
Date
Employees
Jan 1, 2018
20.00 TWD
Jan 1, 2019
20.00 TWD
Jan 1, 2020
20.00 TWD
Jan 1, 2021
20.00 TWD
Jan 1, 2022
20.00 TWD
Jan 1, 2023
20.00 TWD
Jan 1, 2024
20.00 TWD
Jan 1, 2025
20.00 TWD
The MegaPro Biomedical Co Employees history
YEAREmployeesYoY
200.00%
200.00%
200.00%
200.00%
200.00%
200.00%
200.00%
20—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

MegaPro Biomedical Co Stock analysis

What does MegaPro Biomedical Co do? MegaPro Biomedical Co., Ltd. generates revenue through its development of drug ingredients utilizing nanoparticle and nanocell technology platforms. The company's primary products are MPB-1514, MPB-1523, MPB-1734, and MPB-2043, each targeting specific medical conditions. MPB-1514 treats anemia in chronic kidney disease patients via intravenous injection, while MPB-1523 diagnoses hepatocellular carcinoma through intravenous administration. MPB-1734 addresses solid tumors with intravenous treatment, and MPB-2043 aids in diagnosing metastases in peripheral lymph nodes of cancer sites. These products are sold to healthcare providers and medical institutions requiring advanced diagnostic and therapeutic solutions. The company focuses on two core technology platforms: nanoparticle and nanocell, which underpin its product development. Its product portfolio targets chronic kidney disease, hepatocellular carcinoma, solid tumors, and cancer metastasis diagnostics. These applications are directed toward medical professionals and facilities specializing in oncology and nephrology. The firm's revenue model relies on the commercialization of these specialized drug ingredients for targeted medical treatments and diagnostics. MegaPro Biomedical's products are designed for intravenous use across various medical conditions, positioning the company within the biotechnology sector. Its revenue streams come from the sale of these proprietary drug ingredients to hospitals, clinics, and research institutions. The company's market segments include healthcare providers treating kidney disease, cancer diagnostics, and oncology-focused medical facilities seeking innovative therapeutic solutions. MegaPro Biomedical Co is one of the most popular companies on Eulerpool.

Employees Details

Examining MegaPro Biomedical Co's Employee Base

MegaPro Biomedical Co's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding MegaPro Biomedical Co's operational capacity and future potential.

Year-to-Year Comparison

Assessing MegaPro Biomedical Co's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

MegaPro Biomedical Co's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in MegaPro Biomedical Co’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about MegaPro Biomedical Co stock

The number of employees of MegaPro Biomedical Co is 20 in 2025.

The number of employees of MegaPro Biomedical Co changed from 20.00 to 20, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of employees MegaPro Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The number of employees describes the number of people directly employed by the company.

The number of employees's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The number of employees's MegaPro Biomedical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — MegaPro Biomedical Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — MegaPro Biomedical Co